121 related articles for article (PubMed ID: 38158930)
1. Self-sampling for human papilloma virus DNA as a strategy to increase access to cervical cancer screening: patients' and providers' perspectives on facilitators and barriers to scale.
Lathrop E; Chissano M; Tevir G; Chongo Y; Cambe E; Chivambo E; Hoover H; Bouanchaud P
Afr J Reprod Health; 2023 Dec; 27(12):106-111. PubMed ID: 38158930
[TBL] [Abstract][Full Text] [Related]
2. Facilitators and Barriers to HPV Self-Sampling as a Cervical Cancer Screening Option among Women Living with HIV in Rural Uganda.
Nyabigambo A; Mayega RW; Hlongwana K; Ginindza TG
Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297609
[No Abstract] [Full Text] [Related]
3. Leveraging COVID-era innovation for cervical cancer screening: Clinician awareness and attitudes toward self-sampling and rapid testing for HPV detection.
Rodriguez NM; Brennan LP; Claure L; Balian LN; Champion VL; Forman MR
PLoS One; 2023; 18(3):e0282853. PubMed ID: 36893182
[TBL] [Abstract][Full Text] [Related]
4. Acceptability and Feasibility of Human Papilloma Virus Self-Sampling for Cervical Cancer Screening.
Ilangovan K; Kobetz E; Koru-Sengul T; Marcus EN; Rodriguez B; Alonzo Y; Carrasquillo O
J Womens Health (Larchmt); 2016 Sep; 25(9):944-51. PubMed ID: 26890012
[TBL] [Abstract][Full Text] [Related]
5. Perspectives of women participating in a cervical cancer screening campaign with community-based HPV self-sampling in rural western Kenya: a qualitative study.
Oketch SY; Kwena Z; Choi Y; Adewumi K; Moghadassi M; Bukusi EA; Huchko MJ
BMC Womens Health; 2019 Jun; 19(1):75. PubMed ID: 31196175
[TBL] [Abstract][Full Text] [Related]
6. Reach and effectiveness of an HPV self-sampling intervention for cervical screening amongst under- or never-screened women in Toronto, Ontario Canada.
Devotta K; Vahabi M; Prakash V; Lofters A
BMC Womens Health; 2023 Jan; 23(1):36. PubMed ID: 36698140
[TBL] [Abstract][Full Text] [Related]
7. Comparison between self sampling and provider collected samples for Human Papillomavirus (HPV) Deoxyribonucleic acid (DNA) testing in a Nigerian facility.
Ajenifuja OK; Ikeri NZ; Adeteye OV; Banjo AA
Pan Afr Med J; 2018; 30():110. PubMed ID: 30364362
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and sociodemographic predictors of high-risk vaginal human papillomavirus infection: findings from a public cervical cancer screening registry.
Jailani AS; Balqis-Ali NZ; Tang KF; Fun WH; Samad SA; Jahaya R; Subakir NN; Ismail R; Said ZM; Sararaks S
BMC Public Health; 2023 Nov; 23(1):2243. PubMed ID: 37964260
[TBL] [Abstract][Full Text] [Related]
9. Preferred Location for Human Papillomavirus Self-Sampling for Cervical Cancer Screening.
Liebermann E; Fontenot HB; Lim E; Matsunaga M; Zimet G; Allen JD
J Obstet Gynecol Neonatal Nurs; 2023 Sep; 52(5):364-373. PubMed ID: 37355248
[TBL] [Abstract][Full Text] [Related]
10. Mailing human papillomavirus self-sampling kits to women under-screened for cervical cancer improved detection in cervical cancer screening in a general population study in Japan.
Nishimura Y; Matsuura M; Terada N; Nagao S; Shimada H; Isoyama K; Tamate M; Iwasaki M; Saito T
BMC Public Health; 2023 Mar; 23(1):473. PubMed ID: 36906527
[TBL] [Abstract][Full Text] [Related]
11. Acceptability and Concordance of Self- Versus Clinician- Sampling for HPV Testing among Rural South Indian Women.
Madhivanan P; Nishimura H; Ravi K; Pope B; Coudray M; Arun A; Krupp K; Jayakrishna P; Srinivas V
Asian Pac J Cancer Prev; 2021 Mar; 22(3):971-976. PubMed ID: 33773563
[TBL] [Abstract][Full Text] [Related]
12. Barriers and Facilitators to Cervical Cancer Screening Among Women in Rural Ontario, Canada: The Role of Self-Collected HPV Testing.
Racey CS; Gesink DC
J Rural Health; 2016; 32(2):136-45. PubMed ID: 26265118
[TBL] [Abstract][Full Text] [Related]
13. Acceptability of self-collected versus provider-collected sampling for HPV DNA testing among women in rural El Salvador.
Rosenbaum AJ; Gage JC; Alfaro KM; Ditzian LR; Maza M; Scarinci IC; Felix JC; Castle PE; Villalta S; Miranda E; Cremer ML
Int J Gynaecol Obstet; 2014 Aug; 126(2):156-60. PubMed ID: 24880188
[TBL] [Abstract][Full Text] [Related]
14. Ethnographic study of the barriers and facilitators to implementing human papillomavirus (HPV) self-sampling as a primary screening strategy for cervical cancer among Inuit women of Nunavik, Northern Quebec.
Gamelin R; Hébert M; Tratt E; Brassard P
Int J Circumpolar Health; 2022 Dec; 81(1):2032930. PubMed ID: 35166191
[TBL] [Abstract][Full Text] [Related]
15. Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays.
Tranberg M; Jensen JS; Bech BH; Andersen B
BMC Infect Dis; 2020 Dec; 20(1):926. PubMed ID: 33276740
[TBL] [Abstract][Full Text] [Related]
16. Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study.
Bertucci M; Bonnet E; Satger L; Kreiche A; Chappert JL; Loy-Morel S; Segondy M; Daurès JP; Boulle N
Women Health; 2021 Jan; 61(1):83-94. PubMed ID: 33106125
[TBL] [Abstract][Full Text] [Related]
17. Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System.
Parker SL; Amboree TL; Bulsara S; Daheri M; Anderson ML; Hilsenbeck SG; Jibaja-Weiss ML; Zare M; Schmeler KM; Deshmukh AA; Chiao EY; Scheurer ME; Montealegre JR
Am J Prev Med; 2024 Mar; 66(3):540-547. PubMed ID: 37935320
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled trial of two strategies of offering the home-based HPV self-sampling test to non- participants in the Flemish cervical cancer screening program.
Kellen E; Benoy I; Vanden Broeck D; Martens P; Bogers JP; Haelens A; Van Limbergen E
Int J Cancer; 2018 Aug; 143(4):861-868. PubMed ID: 29569715
[TBL] [Abstract][Full Text] [Related]
19. Cervical Cancer Screening Preferences Among Trans-Masculine Individuals: Patient-Collected Human Papillomavirus Vaginal Swabs Versus Provider-Administered Pap Tests.
McDowell M; Pardee DJ; Peitzmeier S; Reisner SL; Agénor M; Alizaga N; Bernstein I; Potter J
LGBT Health; 2017 Aug; 4(4):252-259. PubMed ID: 28665783
[TBL] [Abstract][Full Text] [Related]
20. Comparison of two invitation-based methods for human papillomavirus (HPV) self-sampling with usual care among un- and under-screened Māori, Pacific and Asian women: study protocol for a randomised controlled community trial to examine the effect of self-sampling on participation in cervical-cancer screening.
Brewer N; Bartholomew K; Maxwell A; Grant J; McPherson G; Wihongi H; Bromhead C; Scott N; Crengle S; Cunningham C; Douwes J; Potter JD
BMC Cancer; 2019 Dec; 19(1):1198. PubMed ID: 31815615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
